Immutep Limited (ASX: IMM) Reports Initial Safety Data for IMP761
Immutep Limited announces positive initial safety data for its LAG-3 agonist IMP761 from a Phase I human trial.
Category: Healthcare
Pantoro Limited (ASX:PNR) Finalises Mining Agreement with Ngadju
Pantoro Limited finalises a Mining Agreement with Ngadju Native Title Aboriginal Corporation for its Norseman Gold Project.
PainChek Limited (ASX:PCK) Completes AUD $5.1 Million Entitlement Offer
PainChek Limited completes a successful Entitlement Offer, raising AUD $5.1 million for market expansion and product development.
Patrys Limited (ASX:PAB) Receives R&D Tax Incentive Refund
Patrys Limited (ASX:PAB) secures $1.285 million in R&D Tax Incentive funding to advance its therapeutic antibody development initiatives.
Chimeric Therapeutics (ASX:CHM) Advances Phase 1B AML Trial
Chimeric Therapeutics (ASX:CHM) advances its ADVENT-AML Phase 1B trial for newly diagnosed AML patients.
Invex Therapeutics Limited (ASX:IXC) Announces Positive Exenatide Results
Invex Therapeutics Limited (ASX:IXC) reports significant findings on Exenatide’s efficacy in neuronal cell survival using a 3D brain model for Alzheimer’s Disease.
Aura Energy Limited (ASX:AEE) Announces Significant Ore Reserve Growth
Aura Energy (ASX:AEE) has reported a 49% increase in Ore Reserves to 62.8Mt at the Tiris Uranium Project, enhancing project viability.
4DMedical Limited (ASX:4DX) Secures Contract with University of Chicago Medicine
4DMedical Limited (ASX:4DX) has secured a contract with University of Chicago Medicine to enhance lung imaging and care.
INOVIQ Limited (ASX:IIQ) Advances Exosome Therapy for Breast Cancer
INOVIQ Limited (ASX:IIQ) announces successful proof of concept for exosome therapy targeting breast cancer.
Aurora Energy Metals Limited (ASX:1AE) Reports Significant Recovery Improvements
Aurora Energy Metals (ASX:1AE) announces significant uranium recovery improvements in its Aurora Uranium Project, achieving rates over 85%.